Infarction Register

Acute Coronary Syndrome Clinical Trial

— ADMIRE  

Official title:

Aachen Digital Myocardial Infarction Register

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00763945
• Other study ID #: ADMIRE
• Status: Completed
• Phase: N/A
• First received: September 29, 2008
• Last updated: September 17, 2009
• Start date: March 2006
• Est. completion date: March 2009

Study information

• Verified date: September 2009
• Source: RWTH Aachen University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The Aachener Digitale Myokardinfarkt Register (ADMIRE) is a prospektive registry study which was designed in order to obtain data of patients with acute coronary syndrome and herewith control and optimize guideline conform therapy of these patients.

Description:

Aims of this registry stdy are

documentation of the characteristics of all patients representing to the RWTH Aachen University Hospital (UKA) with STEMI or NSTEMI documentation of the invasive and adjuvant medicinal therapy of STEMI and NSTEMI at UKA documentation of the in-hospital mortality documentation of the procedure-associated complications documentation of therapeutic principals for patients with STEMI or NSTEMI at UKA and investigation conformity of treatment with already established guidelines

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5000
• Est. completion date: March 2009
• Est. primary completion date: March 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• acute coronary syndrome

Exclusion Criteria:

• under age or not able to give informed consent

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Acute Coronary Syndrome

Intervention

Other:
• data collection
The data of patients is collected from their hospital documentation The follow-up of all patients is done via phone calls in order to collect data about the outcome of each patient

Locations

Country	Name	City	State
Germany	Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine at the University Hospital, RWTH Aachen	Aachen	NRW

Sponsors (1)

Lead Sponsor	Collaborator
RWTH Aachen University

Country where clinical trial is conducted

Germany,